接受调强放疗的长期鼻咽癌幸存者认知与神经行为障碍的横断面研究
该横断面研究评估了102例接受调强放疗后≥4年的鼻咽癌幸存者,发现32%存在MoCA认知损害,患者及家属报告的治疗后冷漠、去抑制和执行功能障碍发生率较高且较治疗前显著恶化,并与生活质量下降及焦虑抑郁相关;颞叶接受>75 Gy与上述神经行为症状加重相关,但MoCA总分与放疗剂量无关。
要点
- 102例调强放疗后≥4年鼻咽癌幸存者中,32%MoCA评分<23提示认知损害。
- 患者及家属报告的治疗后FrSBe总分均达临床损害范围,冷漠、去抑制和执行功能障碍较治疗前显著恶化(p<0.001)。
- 颞叶接受>75 Gy与冷漠、去抑制和执行功能障碍加重相关,但MoCA总分与放疗剂量无关。
核心结论
- 接受调强放疗的鼻咽癌幸存者存在中度至高度的神经认知损害率以及具有临床意义的冷漠、去抑制和执行功能障碍。
研究设计与样本
- 横断面队列研究,纳入102例接受调强放疗后≥4年的鼻咽癌幸存者,男女比为66:36,中位年龄56岁(范围32-77岁),中位距调强放疗时间7.5年(范围4.2-11.1年)。
主要发现
- 33例(32%)MoCA评分<23提示认知损害。
- 患者及家属报告的病前神经行为症状FrSBe总分分别为53.3和59.0,处于正常范围;治疗后总分分别为64.7和71.3,达到临床损害范围,冷漠、去抑制和执行功能障碍均较治疗前显著恶化(p<0.001)。
- 患者报告的治疗后临床显著障碍发生率分别为冷漠48%、去抑制35%、执行功能障碍39%;家属报告分别为冷漠66%、去抑制53%、执行功能障碍56%。
- 治疗后神经行为症状与较低生活质量(r=-0.62)、较高焦虑(r=0.62)和抑郁评分(r=0.67)强相关(均p<0.001)。
- MoCA总分与放疗剂量无关;但冷漠、去抑制和执行功能障碍的加重与颞叶接受>75 Gy相关。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE/OBJECTIVES: To determine neurocognitive and neurobehavioral impairment in long-term nasopharyngeal cancer survivors (NPC) treated with intensity-modulated radiotherapy (IMRT). MATERIALS/METHODS: A cross-sectional cohort of NPC ≥4 years (y) following IMRT was assessed. Objective cognitive function was measured using the Montreal Cognitive Assessment (MoCA) and patient-reported memory was assessed with the MDASI-HN problems remembering item. Patient and family ratings of patients' neurobehavioral symptoms of apathy, disinhibition and executive dysfunction were assessed with the Frontal Systems Behavior Scale (FrSBe). Other patient-reported symptoms (MDASI-HN), mood (HADS), and quality of life (FACT-H&N) were also collected. RESULTS: Among 102 participants: M:F = 66:36; median age 56y (32-77); median time since IMRT 7.5y (4.2-11.1). Impaired MoCA scores (<23) were observed in 33 (32%). Patient and family ratings of pre-illness neurobehavioral symptoms were in the normal range (total FrSBe T-scores 53.3 and 59.0 respectively). In contrast, post-treatment patient and family T-scores were clinically impaired (64.7, 71.3 respectively), with apathy, disinhibition and executive dysfunction post-treatment ratings all significantly worse than pre-treatment (p < 0.001). Prevalence of clinically significant post-treatment disturbance was high by patient and family ratings (48%/66% apathy, 35%/53% disinhibition, 39%/56% executive dysfunction). Post-treatment neurobehavioral symptoms strongly correlated with lower quality of life (r = -0.62) and higher anxiety (r = 0.62) and depression scores (r = 0.67, all p < 0.001). Total MoCA scores did not correlate with RT dose. However, greater declines in apathy, disinhibition and executive dysfunction were associated with receiving >75 Gy to temporal lobes. CONCLUSION: NPC treated with IMRT had moderate to high rates of neurocognitive impairment and clinically significant apathy, disinhibition, and executive dysfunction.
引用
- McDowell LJ, Ringash J, Xu W, et al. A cross sectional study in cognitive and neurobehavioral impairment in long-term nasopharyngeal cancer survivors treated with intensity-modulated radiotherapy. Radiother Oncol. 2018. PMID: 30279047. doi:10.1016/j.radonc.2018.09.012
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。